-
Integrating Agentic AI With LLM Workflows for Cohort Comparison in Healthcare Analytics
Sep 9, 2025, 16:22 PM -
From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe
Sep 9, 2025, 16:22 PM -
Application of Budget Impact Model in Evaluation of P2P Payment Strategy in US Health Systems
Sep 9, 2025, 16:22 PM -
Association of eGFR Decline and Cardiovascular Outcomes in Chronic Kidney Disease Patients: Feasibility of Frequency Matching Replicating Event-Driven Clinical Trials With Real-World Data Long-Term
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Health2Sync Application With Patient Management Program Compared to Traditional Care for Patients With Type 2 Diabetes Mellitus in Taiwan
Sep 9, 2025, 16:22 PM -
Structured Expert Elicitation for Survival Outcomes: Insights From NICE Technical Support Document 26
Sep 9, 2025, 16:22 PM -
Strengths and Limitations of AI-Assisted Abstract Screening to Identify Patient-Reported Outcome Instruments: A Comparison of Two AI-Assisted Platforms and Traditional Methods
Sep 9, 2025, 16:22 PM -
Estimated Long-Term Healthcare Cost Savings From EVP Use in the UK
Sep 9, 2025, 16:22 PM -
Cost-Utility of Intramuscular Testosterone for Men and Male Adolescents With Organic Hypogonadotropic Hypogonadism in Brazil
Sep 9, 2025, 16:22 PM -
Trends and Disparities in Prostate Cancer Incidence Prevalence and Survival: A SEER Analysis 2000-2022
Sep 9, 2025, 16:22 PM -
Prognostic Factor Evaluation for Clinical Outcomes in HER2-Mutant NSCLC
Sep 9, 2025, 16:22 PM -
Advocating From the Margins: How Patient Input Aligns With Broader Evidence Tolerance in HTA Within Oncology
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization Among Adults With Pneumococcal Disease in England 2017-2022: A Retrospective Database Analysis
Sep 9, 2025, 16:22 PM -
System-Level Economic Impact of a Combination Influenza-COVID-19 Vaccine vs. Standalone Vaccinations in the United Kingdom
Sep 9, 2025, 16:22 PM -
Antibody-Drug Conjugates in Colorectal Cancer: A Scoping Review of Current Evidence and Emerging Clinical Trends
Sep 9, 2025, 16:22 PM -
Considerations for Modeling Caregiver Spillover Within Economic Evaluations for Neurological Disorders: Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), and Multiple Sclerosis (MS)
Sep 9, 2025, 16:22 PM -
Dihydropyrimidine Dehydrogenase (DPYD) Genetic Testing Before Fluoropyrimidine-Based Adjuvant Chemotherapy for Colorectal Cancer in Qatar: A Cost-Effective Approach
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of Adjuvanted Influenza Vaccine in the Older Adult Population in the Netherlands
Sep 9, 2025, 16:22 PM -
Digital Divide in Health Information Seeking: Rural and Urban Differences in the Use of Online Health Tools in the United States
Sep 9, 2025, 16:22 PM -
The Economic Value of Diagnostic Strategies in Hepatitis D: A Methodological Review of Cost-Effectiveness Models
Sep 9, 2025, 16:22 PM
